Organovo Holdings Inc. (NASDAQ: ONVO)
$0.61
-0.0660 ( -9.73% ) 1.5M
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
Market Data
Open
$0.61
Previous close
$0.68
Volume
1.5M
Market cap
$8.91M
Day range
$0.56 - $0.85
52 week range
$0.56 - $2.05
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Aug 22, 2023 |
| 10-q | Quarterly Reports | 55 | Aug 10, 2023 |
| 10-k/a | Quarterly Reports | 14 | Jul 31, 2023 |
| 8-k | 8K-related | 13 | Jul 24, 2023 |
| pre | Proxies and info statements | 23 | Jul 14, 2023 |
| 10-k | Annual reports | 78 | Jul 14, 2023 |